News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RTI Surgical (RTIX) Announces First Implantation of map3™ Cellular Allogeneic Bone Graft in a Foot and Ankle Procedure


9/25/2013 9:23:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a global surgical implant company, is pleased to announce the first implantation of the company’s map3™ Cellular Allogeneic Bone Graft implant in a foot and ankle procedure.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES